Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTX-011 in Multimodal Analgesic Regimen for Postoperative Pain After Inguinal Herniorrhaphy
NCT03695367Phase 2Completed
- Sponsor
- Heron Therapeutics, Inc.
- Start
- Oct 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine + meloxicam in postoperative pain, sponsored by Heron Therapeutics, Inc.. Started Oct 2018; status: completed.
02
Drugs
bupivacaine + meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03695367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03695367.